The role of exercise radionuclide angiocardiography in predicting future cardiac events in patients with acute myocardial infarction

Citation
T. Shigeyama et al., The role of exercise radionuclide angiocardiography in predicting future cardiac events in patients with acute myocardial infarction, J NUCL MED, 41(6), 2000, pp. 965-972
Citations number
35
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF NUCLEAR MEDICINE
ISSN journal
01615505 → ACNP
Volume
41
Issue
6
Year of publication
2000
Pages
965 - 972
Database
ISI
SICI code
0161-5505(200006)41:6<965:TROERA>2.0.ZU;2-K
Abstract
Left ventricular ejection fraction (LVEF) during exercise radionuclide angi ocardiography is a useful prognostic index for patients with acute myocardi al infarction (AMI). However, most previous studies were performed before r eperfusion therapies (i.e., thrombolysis and coronary angioplasty) were wid ely used. Therefore, because reperfusion therapy has become a standard ther apeutic option, we reexamined the prognostic value of rest LVEF and exercis e LVEF determined by radionuclide angiocardiography in patients with AMI at the time of hospital discharge. Methods: The retrospective analysis includ ed 419 consecutive patients with AMI who underwent ergometric stress radion uclide angiocardiography before hospital discharge, 44 +/- 14 d after the o nset of AMI. Results: During a mean follow-up of 4.6 y, cardiac events occu rred in 101 (24.1%) patients. Cardiac events included recurrent MI (33 pati ents, 7.9%), unstable angina (49 patients, 11.7%), congestive heart failure (16 patients, 3.8%), and ventricular tachycardia (3 patients, 0.7%). The L VEF at peak exercise was significantly lower in the group with cardiac even ts (P = 0.0140). However, no significant difference was observed in the res t LVEF between patients with and without cardiac events. On the basis of mu ltivariate analysis using a Cox proportional hazards model, only peak LVEF (P = 0.0246) was found to be an independent predictor of cardiac events. In the patient subsets with a peak LVEF >50% or <50%, the event-free rate was 81.0% versus 62.4% (P = 0.0007), respectively. Regardless of the presence or absence of reperfusion therapy, the lower peak LVEF was associated with a decrease in the event-free survival rate. Conclusion: In the current repe rfusion era, the lower peak LVEF as measured by radionuclide angiocardiogra phy at the time of discharge is a useful predictor of subsequent cardiac ev ents in patients with AMI.